E-LIB Suche - Ergebnisse für: Bruno, Christopher D.

1

Perspectives on the use of ceftolozane/tazobactam: a review..:

Martin-Loeches, Ignacio ; Bruno, Christopher J ; DeRyke, C Andrew
Future Microbiology. 19 (2024) 6 - p. 465-480 , 2024

Link: https://doi.org/10.2217/..

2

A population pharmacokinetic model for posaconazole intrave..:

Winchell, Gregory ; de Greef, Rik ; Ouerdani, Aziz...
Antimicrobial Agents and Chemotherapy. 68 (2024) 4 - p. , 2024

Link: https://doi.org/10.1128/..

3

Safety, tolerability, and immunogenicity of an adult pneumo..:

Platt, Heather L ; Bruno, Christopher ; Buntinx, Erik...
The Lancet Infectious Diseases. , 2024

Link: https://doi.org/10.1016/..

4

P21 A Phase 3 randomized, double-blind, active comparator-c..:

Bruno, Christopher ; Buntinx, Erik ; Pelayo, Enrique...
JAC-Antimicrobial Resistance. 6 (2024) Supplement_1 - p. , 2024

Link: https://doi.org/10.1093/..

5

Safety and Efficacy of Ceftolozane/Tazobactam Versus Merope..:

Roilides, Emmanuel ; Ashouri, Negar ; Bradley, John S....
Pediatric Infectious Disease Journal. 42 (2023) 4 - p. 292-298 , 2023

Link: https://doi.org/10.1097/..

6

Estimation of Absolute and Relative Body Fat Content Using ..:

Greenblatt, David J. ; Bruno, Christopher D. ; Harmatz, Jerold S....
The Journal of Clinical Pharmacology. 63 (2023) S2 - p. , 2023

Link: https://doi.org/10.1002/..

7

Safety and Efficacy of Ceftolozane/Tazobactam Plus Metronid..:

Jackson, Carl-Christian A. ; Newland, Jason ; Dementieva, Nataliia...
Pediatric Infectious Disease Journal. 42 (2023) 7 - p. 557-563 , 2023

Link: https://doi.org/10.1097/..

8

Subgroup analysis of phase 2 study of ceftolozane/tazobacta..:

Roilides, Emmanuel ; Bradley, John S. ; Lonchar, Julia...
Microbiology Spectrum. 11 (2023) 5 - p. , 2023

Link: https://doi.org/10.1128/..

9

Clinical Consequences of Altered Drug Disposition in Obesit..:

Bruno, Christopher D. ; Greenblatt, David J. ; Harmatz, Jerold S..
The Journal of Clinical Pharmacology. 63 (2023) S2 - p. , 2023

Link: https://doi.org/10.1002/..

10

Outcomes in participants with ventilated nosocomial pneumon..:

Martin-Loeches, Ignacio ; Shorr, Andrew F. ; Wunderink, Richard G....
Annals of Intensive Care. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

11

Incomplete Data and Potential Risks of Drugs in People with..:

Apovian, Caroline M. ; Bruno, Christopher D. ; Kyle, Theodore K...
Current Obesity Reports. 12 (2023) 4 - p. 429-438 , 2023

Link: https://doi.org/10.1007/..

12

Exposure–Efficacy Analyses Support Optimal Dosing Regimens ..:

Gao, Wei ; Passarell, Julie ; Patel, Yogesh T....
Antimicrobial Agents and Chemotherapy. 66 (2022) 5 - p. , 2022

Link: https://doi.org/10.1128/..

13

Locating the Future of ESG: The Promise of Geospatial Data ..:

Atz, Ulrich ; Bruno, Christopher
Sustainability and Climate Change. 16(1) (2022) 2–9 - p. , 2022

Link: https://ssrn.com/abstrac..

14

Clinical and microbiological outcomes, by causative pathoge..:

Martin-Loeches, Ignacio ; Timsit, Jean-François ; Kollef, Marin H....
Journal of Antimicrobial Chemotherapy. 77 (2022) 4 - p. 1166-1177 , 2022

Link: https://doi.org/10.1093/..

15

Drug Disposition in Subjects With Obesity: The Research Wor..:

Greenblatt, David J. ; Bruno, Christopher D. ; Harmatz, Jerold S...
The Journal of Clinical Pharmacology. 62 (2022) 11 - p. 1350-1363 , 2022

Link: https://doi.org/10.1002/..